Biological e. - Latest News Update, Information, Photos & Videos on Biological e. at Lokmat Times

The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.The announcement is part of the agency's Global Health and Prosperity Initiative, under which the agency is working to increase manufacturing, production and distribution capacity for vaccines, including the COVID-19 vaccine.The Biden-Harris Administration highlighted the announcement during the Quad Summit, at which the leaders from the US, Australia, India, and Japan announced a landmark partnership to further accelerate the end of the COVID-19 pandemic.The first Quad summit was held on Friday in a virtual format.A DFC release said Biological E is a woman-run and woman-operated business, advancing DFC's 2X Women's Initiative to promote global gender equity."DFC will work with Indian manufacturer Biological E Ltd. to finance increased capacity to support Biological E's effort to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022," the release said."The vaccines Biological E plans to produce with the assistance of DFC's financing complement existing efforts to vaccinate as many people in the world as possible in the shortest amount of time," it added.DFC Chief Operating Officer David Marchick said expanding vaccine manufacturing, especially the COVID-19 vaccine and boosters, will help increase vaccination rates and protect communities around the world."It is hard to conceive of an investment with a greater developmental impact than using our financial tools to increase the capacity of vaccine manufacturing to help developing countries in Asia and around the world respond to COVID-19 and other diseases," he said.The release said that under its development strategy Roadmap for Impact, DFC is strengthening global health systems by working to provide businesses with financing to increase capacity in the manufacturing, production and distribution of vaccines, including the COVID-19 vaccine.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Biological E.FOLLOW

Biological e., Latest News

Health :Corbevax price slashed to Rs 250 per dose

Hyderabad, May 16 Vaccine maker Biological E. Ltd (BE) on Monday announced that it has reduced the price ... ...

Health :Centre to begin Covid vaccination for 12-14 age group from March 16

New Delhi, March 14 The Union Government after deliberations with scientific bodies decided on Monday to start Covid ... ...

National :Centre has placed purchase order for 5 crore Corbevax COVID-19 vaccine doses, say sources

The Central government has placed an order with Hyderabad based Pharmaceutical company Biological E for five crore doses of 'Corbevax' COVID-19 vaccine with each dose costing Rs 145, said sources. ...

International :DFC to support Indian manufacturer Biological E's efforts to produce 1 billion COVID-19 vaccines by 2022

The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization ( ...